EHP Funds Inc’s Meridian Bioscience Inc VIVO Stock Holding History

EHP Funds Inc’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-144,196	Closed	-$4.79M	–	380
2022 Q4	$4.79M	Sell	144,196 -15,804	-10%	-$509K	0.9%	10
2022 Q3	$5.04M	Buy	+160,000	New	+$5.18M	1.02%	13

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

EHP Funds Inc's VIVO Position: Q1 2023 in Review

EHP Funds Inc sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 144,196 shares — an estimated $4.79M sold.

EHP Funds Inc first reported a position in VIVO in Q3 2022 and held it in 2 quarters. The position peaked at $5.04M in Q3 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

EHP Funds Inc reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
EHP Funds Inc sold 144,196 Meridian Bioscience Inc shares in Q1 2023, an estimated $4.79M.
EHP Funds Inc first reported a position in Meridian Bioscience Inc in Q3 2022 and held it in 2 quarters.
EHP Funds Inc's Meridian Bioscience Inc position peaked at $5.04M in Q3 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on EHP Funds Inc's 13F filing for Q1 2023, filed 15 May 2023.